Nucleotide Chemical Synthesis Service
Characterization of Nucleotides
Nucleotides are a class of compounds consisting of three substances: purine or pyrimidine bases, ribose or deoxyribose, and phosphate. Nucleotides are essential tools for regulating gene expression in biomedical and life sciences research and have been developed as gene-targeted therapeutic agents for the treatment of viruses, and tumors. Nucleotide drugs mainly include antisense oligonucleotides, small interfering RNAs, ribozymes, deoxy ribozymes, transgenes, CpG oligonucleotides, transcription factor decoys, and nucleic acid aptamers. Natural nucleotides are easily degraded in vivo, have low specificity, and have toxic side effects. Therefore, drug nucleotides usually carry specific modifying groups, such as thiophosphate diester bond, fluorine substitution, methylation, and locked nucleic acid, etc., to enhance the stability of nucleotides in vivo, improve specificity, and reduce their toxic side effects. Based on the importance of nucleotides to the human body and the prospect of their development in the pharmaceutical industry, a comprehensive study of nucleotides is imminent.
Key Technologies
At CD BioGlyco, our nucleotide chemical synthesis service is built upon a foundation of proven methodologies and innovative advancements in synthetic organic chemistry.
- Pyrophosphate Bond Formation
Our primary approach for nucleoside diphosphate (NDP) sugars focuses on the efficient formation of the pyrophosphate bond from two monophosphate precursors – a nucleoside monophosphate and a glycosyl phosphate.
- Khorana phosphoromorpholidate chemistry
This is a cornerstone of our methodology, widely recognized for its stereochemically unambiguous nature and high yields. We utilize nucleoside phosphoromorpholidates, readily prepared in our laboratories via activation with N,N'-dicyclohexylcarbodiimide (DCC) or through Mukaiyama's redox condensation conditions, which can offer simplified purification. This method is highly effective for synthesizing a broad spectrum of natural and non-natural sugar-nucleotides, including those with unusual sugar moieties or fragile anomeric linkages. The use of protected sugar phosphates (e.g., acetylated) is often incorporated to enhance reaction rates and streamline purification.
- Carbonyldiimidazole (CDI) activation
Complementing the Khorana method, CDI activation is employed for forming pyrophosphate bonds. This versatile method provides comparable yields and reaction times to morpholidate activation in many cases, demonstrating reduced dependency on specific solvents and additives. We strategically apply CDI activation, especially with protected sugar phosphates, to optimize reaction kinetics and product purification.
- Phosphoramidite Chemistry (PIII Chemistry)
For certain complex or novel nucleotide structures, we leverage advanced PIII chemistry. This approach involves the condensation of silyl-protected sugar phosphates with phosphoramidite intermediates, followed by in situ oxidation and global deprotection. This methodology is particularly valuable for its impressive yields and operational simplicity, offering a highly efficient route to specific UDP-sugars and their non-natural congeners.
- Glycosylation of Nucleoside Diphosphates
Where applicable, we employ strategies involving the direct glycosylation of a nucleoside diphosphate with an electrophilic glycosyl donor. This method offers significant structural variation due to the commercial availability of numerous NDPs. Our expertise in controlling stereoselectivity, including the use of neighboring group participation from protecting groups (e.g., acetate or benzoate at position 2) on glycosyl donors, allows us to achieve pure anomeric products for specific sugars like α-D-mannose or β-L-fucose.
Precision-Synthesized Nucleotides: Accelerate Discovery
Nucleotide production methods are mainly divided into chemical and biological (Microbial or Enzymatic) production. CD BioGlyco has many years of experience and is well-versed in the use of chemical methods.
At CD BioGlyco, we produce nucleotides mainly from nucleosides in the presence of phosphorylating reagents. In this route, the complex steps of protection and deprotection are avoided, subsequent purification is simple, and a high yield (90%-95%) is achieved overall. We also offer a wide range of phosphorylation reagents to meet our clients' production needs.
In addition, we offer the following routes to produce nucleotides:
- Preparation of nucleotides from nucleoside derivatives
- Preparation of nucleotides from purine derivatives
- Preparation of nucleotides from deoxyribosides
- Nucleotides from nitrogen-containing polycyclic compounds by phosphorylation
In addition to the production of nucleotides, we also provide structural characterization of nucleotides. We have HPLC, NMR, IR, and other professional techniques for comprehensive analysis of products.
Workflow
- Precursor Sourcing and Preparation
We meticulously source or synthesize all necessary starting materials, including nucleoside monophosphates, glycosyl phosphates, and appropriate protecting group reagents. This stage often involves the in-house preparation of activated precursors, such as nucleoside phosphoromorpholidates, or silyl-protected sugar phosphates, ensuring high quality and reactivity.
- Core Coupling Reaction
This is the central step where the key phosphodiester or pyrophosphate bond is formed. Depending on the chosen strategy, this could involve Khorana-type coupling, CDI activation, or phosphoramidite chemistry. Reactions are conducted under strictly controlled conditions, often anhydrous, to maximize yield and prevent unwanted side reactions or hydrolysis.
- Deprotection and Purification
Following the coupling, any necessary protecting groups are selectively removed under mild conditions to yield the free nucleotide monomer. The crude product undergoes rigorous purification using advanced chromatographic techniques to ensure the highest possible purity, addressing the low solubility and polar nature of these compounds.
- Quality Control and Analysis
The final purified nucleotide monomer undergoes comprehensive quality control analysis. This includes techniques such as NMR spectroscopy for structural confirmation, mass spectrometry for molecular weight verification, and high-performance liquid chromatography for purity assessment and quantification. A detailed certificate of analysis is provided with each delivery.
Publication Data
DOI.: 10.3390/molecules25235755
Journal: Molecules
IF: 4.6
Published: 2020
Results: This review comprehensively explores the multifaceted roles of nucleotide sugars, essential building blocks for carbohydrate and glycoconjugate biosynthesis in all living organisms. It covers their biological significance in mammalian, plant, and bacterial glycosylation pathways, detailing their diverse structures and biosynthetic routes. The article delves into the mechanisms of enzymes utilizing nucleotide sugars (glycosyltransferases, phosphoglycosyltransferases, hydrolases) and analyzes their inherent chemical reactivity and decomposition pathways in solution. It also reviews chemical and enzymatic synthesis methods for natural and modified nucleotide sugars, including chemoenzymatic cascades. The work emphasizes the importance of understanding these molecules for developing therapeutic strategies (e.g., enzyme inhibitors, vaccines) and efficient synthetic routes for oligosaccharides and glycoconjugates.
Applications
- In food processing, nucleotides could be used in the development of flavorings.
- In the pharmaceutical field, nucleotides could be used in the development of anti-tumor and anti-viral drugs.
- Nucleotides can be used as raw materials for the production of plant production regulators and feed additives.
Advantages
- Our chemical synthesis capabilities are unparalleled in delivering non-natural nucleotide monomers and complex structural analogues that are beyond the scope of enzymatic methods.
- Leveraging sophisticated purification techniques and stringent quality control, we ensure the delivery of nucleotide with exceptional purity, critical for sensitive biochemical assays and pharmaceutical applications.
- We employ specialized techniques to handle the inherent challenges, ensuring stable and reliable synthesis.
Frequently Asked Questions
Associated Services
Building on our foundation of precision nucleotide monomer synthesis, we extend our expertise to Chemical-based Oligonucleotide Synthesis Service through two strategically optimized approaches:
CD BioGlyco has many years of research experience in the production of nucleotides. We have a specialized research team that has developed a variety of research protocols in the production of nucleotides. We provide custom nucleotide production solutions to our clients around the world, providing scientific assistance in the development and utilization of nucleotide resources. If you are interested in our services, please feel free to contact us.
Reference
- Mikkola, S. Nucleotide sugars in chemistry and biology. Molecules. 2020, 25(23): 5755. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




